New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

Biogen (BIIB) and Eisai's (ESALF) (ESAIY) announce that U.S. FDA agreed to review their subcutaneous form of Alzheimer's ...

A report questions the FDA's accelerated approval process citing Sarepta and Biogen therapies as examples. Read more here.

Israel Prize winner Prof. Michal Schwartz says her team's work fighting Alzheimer's can lead to treatments that boost immune ...

Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement ...

The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...

Approvals for drugs from Biogen Inc. and Sarepta Therapeutics Inc. show flaws in the process US drug regulators use to speed ...

Scientists have developed a promising method to weaken negative memories by reactivating positive ones during sleep. The study, which involved linking ...

Sleep has been shown to have a long list of physical and mental health benefits, and now a new study suggests it could also ...

ABC News' Dr. Darien Sutton discusses a new study that projects dementia diagnoses in the U.S. will rise to nearly 1 million ...

A Potential Game-Changer for Mental Health TreatmentsSetting New Benchmarks: 65% Response Rate Shown in Completed Depression ...